Nexalin secures US patent for Alzheimer's deep-brain stimulation device [Yahoo! Finance]
Nexalin Technology, Inc. (NXL)
Company Research
Source: Yahoo! Finance
The US Patent and Trademark Office granted U.S. Patent No 12,011,591, which covers Nexalin's advanced Gen-2 and Gen-3 medical device. This brain stimulation medical device is developed to utilise waveform technology to treat patients in a pain-free and undetectable manner. The patent is titled 'Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) Method for Alzheimer's and Dementia'. Said to be a significant advancement to the predecessor Gen-1 system, the Gen-2 and Gen-3 device employs a new approach to brain stimulation, using strategically placed electrodes on the patient's head to deliver deep stimulation to brain regions linked with mental health disorders. According to the company, this technology offers a safe, risk-free and effective treatment option. The Gen-2 and Gen-3 system is the latest development in Nexalin's DIFS technology. Nexalin Technology CEO Mark White said: “The award of this patent marks another major milestone for the company, as
Show less
Read more
Impact Snapshot
Event Time:
NXL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NXL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NXL alerts
High impacting Nexalin Technology, Inc. news events
Weekly update
A roundup of the hottest topics
NXL
News
- Nexalin Technology Announces Pricing of $5.2 Million Public Offering [Yahoo! Finance]Yahoo! Finance
- Nexalin Technology Announces Pricing of $5.2 Million Public OfferingGlobeNewswire
- Nexalin's deep brain stimulation add-on therapy alleviates depression [Yahoo! Finance]Yahoo! Finance
- Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal [Yahoo! Finance]Yahoo! Finance
- Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific JournalGlobeNewswire
NXL
Sec Filings
- 6/28/24 - Form 8-K
- 6/28/24 - Form EFFECT
- 6/26/24 - Form S-1/A
- NXL's page on the SEC website